A new study published in the Journal of Medical Internet Research has found that regular participation in dance classes can ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Parkinson’s Disease has over 40 wide-ranging symptoms, as per the charity, from tremors and mental health issues to blood pressure changes. Those with Parkin 2 often experience these symptoms at ...

Advancing Light Therapy Research to Enhance Quality of Life for Parkinson's Patients This trial is important becau ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...

21, 2025 — The B vitamin mitigates manganese neurotoxicity, which produces symptoms ... motor function, offering a new therapeutic ... A Risky Business: Why Do Some Parkinson's Disease ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

ONAPGOis the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s ...